Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs, SOR/2026-162
Section 1
Definitions
Cite as Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs, SOR/2026-162, s. 1 · current to July 21, 2026 · regulation last amended July 15, 2026
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) The following definitions apply in this Order.
abbreviated new drug submission means an abbreviated new drug submission filed under section C.08.002.1 of the Regulations. (présentation abrégée de drogue nouvelle)
corresponding foreign drug, in respect of the drug that is the subject of a new drug submission, an abbreviated new drug submission or a supplement to either such submission, means
(a) the foreign drug referred to in subparagraph 2(1)(c)(i), clause 3(2)(b)(ii)(A), subparagraph 5(1)(c)(i), subparagraph 6(1)(c)(i) or clause 7(2)(b)(ii)(A), as the case may be; and
(b) any other foreign drug that meets the following criteria:
(i) in the case of a new drug submission or an abbreviated new drug submission,
(A) it belongs to the class of drugs to which the drug that is the subject of the submission belongs,
(B) it has the same strength, dosage form, route of administration and medicinal ingredient as that drug, and
(C) it has conditions of use that fall within the conditions of use of that drug, and
(ii) in the case of a supplement to a new drug submission or to an abbreviated new drug submission,
(A) it belongs to the class of drugs to which the drug that is the subject of the supplement belongs,
(B) it has the same strength, dosage form, route of administration and medicinal ingredient as that drug, as it would be approved if the Minister were to issue a notice of compliance in respect of the supplement, and
(C) it has conditions of use that fall within the conditions of use of that drug, as it would be approved if the Minister were to issue a notice of compliance in respect of the supplement. (drogue étrangère correspondante)
drug means a new drug but does not include a public health emergency drug. (drogue)
List means the document entitled List of Classes of Drugs and Foreign Regulatory Authorities for the Purposes of Reliance on Decisions or Documents, published by the Government of Canada on its website, as amended from time to time. (Liste)
new drug submission means a new drug submission filed under section C.08.002 of the Regulations. (présentation de drogue nouvelle)
notice of compliance means a notice of compliance issued under section C.08.004 of the Regulations. (avis de conformité)
post-market measure means any measure that a foreign regulatory authority provides for in respect of a foreign drug for any of the following purposes:
(a) optimizing the benefits and managing the risks associated with the foreign drug;
(b) managing significant uncertainties relating to those benefits and risks;
(c) collecting information to enable the continuous assessment of those benefits and risks, the identification of any changes to them and the management of the uncertainties. (mesure après la mise en marché)
Regulations means the Food and Drug Regulations. (Règlement)
supplement means a supplement filed under section C.08.003 of the Regulations. (supplément)
(2) Unless the context otherwise requires, words and expressions used in this Order have the same meaning as in Part A or C of the Regulations, as applicable.
(3) Unless the context otherwise requires, in this Order a reference to information includes a reference to material.
Read the Order Providing for Reliance on Decisions of, or Documents Produced by, Foreign Regulatory Authorities in Respect of Certain Drugs on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.